<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Six human hematopoetic cell lines were successfully heterotransplanted into athymic (<z:mp ids='MP_0003815'>nude</z:mp>) and asplenic-athymic (lasat) neonatal mice </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> arising from <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells could then be serially transplanted into adult <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="2" pm="."><plain>Seven days after the fourth serial mouse passage, each mouse was treated with goat immune gamma globulin against K-562 cells </plain></SENT>
<SENT sid="3" pm="."><plain>One control group was treated similarly, but with nonimmune (<z:mpath ids='MPATH_458'>normal</z:mpath>) gamma globulin, while another control group was not treated </plain></SENT>
<SENT sid="4" pm="."><plain>The goat gamma globulin was not toxic for <z:mp ids='MP_0003815'>nude</z:mp> and lasat mice, and the immune, but not the <z:mpath ids='MPATH_458'>normal</z:mpath>, gamma globulin suppressed local subcutaneous growth of <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">myelosarcomas</z:e>, <z:e sem="disease" ids="C0079734" disease_type="Neoplastic Process" abbrv="">lymphosarcomas</z:e>, and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>On the other hand, the growth of lung, breast, and prostatic <z:mp ids='MP_0002038'>carcinomas</z:mp> and a <z:hpo ids='HP_0002861'>melanoma</z:hpo> of human origin were not altered by the immune gamma globulin </plain></SENT>
<SENT sid="6" pm="."><plain>Since suppression of cell growth occurred equally well in decomplemented mice, a complement-mediated cytotoxicity apparently cannot be considered as responsible for the abrogation </plain></SENT>
<SENT sid="7" pm="."><plain>The Fab fragment of the immunoglobulin did not suppress the growth of the <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">myelosarcomas</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that antibody suppression of the in vivo proliferation was specific for malignant hematopoietic cells and that the Fc portion of IgG is necessary for in vivo cytolysis of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="9" pm="."><plain>The most probable mechanisms are direct antibody cytolysis and antibody-dependent macrophage-mediated cytotoxicity </plain></SENT>
</text></document>